AIC
KYNB

Ameritas Investment Company’s Kyntra Bio KYNB Stock Holding History

Ameritas Investment Company’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-70
Closed -$61K – 740
2020
Q1 		$61K Buy
+70
New +$69.6K 0.01% 635
2019
Q4 		– Sell
-56
Closed -$52K – 1056
2019
Q3 		$52K Buy
+56
New +$61.5K 0.01% 652
2019
Q1 		– Sell
-92
Closed -$106K – 1269
2018
Q4 		$106K Buy
+92
New +$103K 0.02% 420

Other funds holding KYNB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Ameritas Investment Company's KYNB Position: Q2 2020 in Review

Ameritas Investment Company sold out of Kyntra Bio (KYNB) in Q2 2020, closing a stake of 70 shares — an estimated $61K sold.

Ameritas Investment Company first reported a position in KYNB in Q4 2018 and held it in 3 quarters. The position peaked at $106K in Q4 2018. 194 funds tracked by Wall St. Rank hold KYNB as of Q2 2020.

  • Ameritas Investment Company reported no remaining Kyntra Bio position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 70 Kyntra Bio shares in Q2 2020, an estimated $61K.
  • Ameritas Investment Company first reported a position in Kyntra Bio in Q4 2018 and held it in 3 quarters.
  • Ameritas Investment Company's Kyntra Bio position peaked at $106K in Q4 2018.
  • 194 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.